Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200GlobeNewswire Nov 9, 2026, 1:30:00 PM
Polaryx Therapeutics Appoints Dr. Will Charlton as Chief Medical OfficerGlobeNewswire Sep 1, 2026, 12:30:00 PM
Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket TrialGlobeNewswire Aug 25, 2026, 12:30:00 PM
Polaryx Therapeutics Gets FDA Fast Track Designations for Its Lead Drug CandidateGlobal News Select Apr 21, 2026, 1:19:00 PM